Please provide your email address to receive an email when new articles are posted on . DALLAS — A study shows that ferric pyrophosphate citrate administered via intraperitoneal delivery can ...
Findings confirm results from previous population PK study demonstrating safe and effective anticoagulation along with the delivery of Ferric Pyrophosphate Citrate iron WIXOM, Mich., Nov. 16, 2021 ...
The Ferric Pyrophosphate Market presents strong growth opportunities driven by rising anemia cases, increasing demand for functional foods, and advancements in renal therapies. However, regulatory ...
Rockwell Medical announced topline results for the PRIME clinical study of soluble ferric pyrophosphate (SFP), its investigational iron–delivery drug in a Phase 3 study for the treatment of iron ...
WIXOM -- Rockwell Medical (Nasdaq: RMTI) Monday announced successful results from a clinical study of Soluble Ferric Pyrophosphate, its investigational iron-delivery drug now in Phase 3 clinical ...
The US Food and Drug Administration (FDA) has approved soluble ferric pyrophosphate (Triferic, Rockwell Medical) to replace iron and maintain hemoglobin in adults with chronic kidney disease who are ...
Triferic is an iron maintenance therapy that delivers between 5 to 7mg of iron with every hemodialysis treatment and maintains hemoglobin without increasing ferritin. Triferic AVNU ® (ferric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results